Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Evogene Ltd Ord
(NQ:
EVGN
)
3.980
-0.070 (-1.73%)
Streaming Delayed Price
Updated: 3:58 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Evogene Ltd Ord
< Previous
1
2
3
Next >
EVGN Stock Earnings: Evogene Beats EPS, Beats Revenue for Q1 2024
May 23, 2024
EVGN stock results show that Evogene beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
EVGN Stock Earnings: Evogene Beats EPS, Misses Revenue for Q4 2023
March 07, 2024
EVGN stock results show that Evogene beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Israeli Company Reports Record 2023 Revenue, Wants To Transition Cannabis Operations To 'Third Party'
March 07, 2024
Evogene Ltd. released its fourth-quarter and full-year 2023 financial results, showing a 237% revenue increase for the year. Despite a 12% revenue decrease in Q4, the Israeli cannabis company reported...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Israeli Cannabis Company Reports Strong Q3 Despite Geopolitical Challenges
November 16, 2023
Evogene reports a strong Q3 with $3.8M revenue and significant gross profit growth, showcasing resilience and innovation in cannabis tech.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Recap: Evogene Q3 Earnings
November 15, 2023
Via
Benzinga
A Preview Of Evogene's Earnings
November 14, 2023
Via
Benzinga
Lake Street Maintains Buy Rating for Evogene: Here's What You Need To Know
August 18, 2023
Via
Benzinga
Earnings Outlook For Evogene
August 16, 2023
Via
Benzinga
Evogene's Casterra Gets $2.2M Orders To Supply Castor Seeds
July 03, 2023
Evogene Ltd. (NASDAQ: EVGN) said its unit Casterra Ag Ltd.
Via
Benzinga
Earnings Scheduled For March 7, 2024
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via
Benzinga
Evogene Earnings Preview
March 06, 2024
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 2, 2023
October 02, 2023
Via
Benzinga
Why Evogene Shares Are Moving
September 21, 2023
Evogene Ltd (NASDAQ: EVGN) shares are trading lower by 5.9% to $0.63 Thursday morning after the company received a letter from the Nasdaq indicating that the company is not in compliance with the...
Via
Benzinga
Israeli Cannabis Co. Reports Solid Q2 Performance, Nearing Growth Targets
August 17, 2023
Cannabis company Evogene Ltd.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Why Evogene Stock Is Tanking Today
July 17, 2023
Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) shares were trading 20% lower at $1.12 per share at the time of writing Monday morning.
Via
Benzinga
TalkMarkets Announces Company Spotlight Featuring Evogene
June 22, 2023
TalkMarkets.com announces a company spotlight series featuring Evogene (NASDAQ: EVGN), an agri-tech and bio-tech company with a computational predictive biological platform technology.
Via
Talk Markets
Evogene: Q1 Earnings Insights
May 18, 2023
Via
Benzinga
Evogene's Earnings Outlook
May 17, 2023
Via
Benzinga
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 17, 2023
Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived...
Via
Benzinga
Why Aehr Test Systems Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
July 14, 2023
Gainers Ainos, Inc. (NASDAQ: AIMD) shares surged 108.2% to $1.52 in pre-market trading after gaining around 7% on Thursday.
Via
Benzinga
TalkMarkets Announces Company Spotlight Featuring Evogene
June 22, 2023
TalkMarkets.com announces a company spotlight series featuring Evogene (NASDAQ: EVGN), an agri-tech (agricultural technology) and bio-tech company with a computational predictive biological platform...
Via
TheNewswire.com
TalkMarkets Announces Company Spotlight Featuring Evogene
June 22, 2023
TalkMarkets.com announces a company spotlight series featuring Evogene (NASDAQ: EVGN), an agri-tech and bio-tech company with a computational predictive biological platform technology.
Via
News Direct
Evogene - A Company With Valuable Assets Trading At Zero Enterprise Value
June 22, 2023
From a sum-of-parts perspective, Evogene is likely worth many multiples of its market valuation today, even without ascribing any value to Evogene’s technology.
Via
Talk Markets
Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 21, 2023
Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 209.5% to $2.29 after the company signed a Letter of Intention with UAE-Based e-script medicine management company Pharmak...
Via
Benzinga
Why Evogene (EVGN) Stock Is Trading Higher
June 21, 2023
Evogene Ltd (NASDAQ: EVGN) shares are trading higher by 13.72% to $0.83 Wednesday morning after the company announced its subsidiary, Casterra, signed a framework agreement with an oil & gas company to...
Via
Benzinga
Tryp Submits IND Application To FDA For Clinical Trial Of Psilocybin-Assisted Psychotherapy In Patients With IBS
May 24, 2023
Tryp Therapeutics, Inc. (OTCQB: TRYPF) (CSE:TRYP) has submitted an Investigational New Drug application to the U.S.
Via
Benzinga
Evogene Q1 Revenue Grows 170% YoY, Here Are The Details
May 18, 2023
Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) released its financial results for the first quarter period ending March 31, 2023, revealing revenues of $641,000, an increase of 170% compared to $237,000 in...
Via
Benzinga
Earnings Scheduled For May 18, 2023
May 18, 2023
Companies Reporting Before The Bell • Lightspeed Commerce (NYSE:LSPD) is projected to report quarterly loss at $0.04 per share on revenue of $248.01 million.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2023
May 02, 2023
Via
Benzinga
Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries
April 27, 2023
Evogene employs an artificial intelligence platform for decoding plant phenotypes and microbial genomes. Consider its' research agenda, applications, and at-the-market products. The set-up may present...
Via
Talk Markets
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.